Mir-22
In molecular biology mir-22 microRNA is a short RNA molecule. MicroRNAs are an abundant class of molecules, approximately 22 nucleotides in length, which can post-transcriptionally regulate gene expression by binding to the 3' UTR of mRNAs expressed in a cell.
Origins
Mir-22 was originally identified in HeLa cells, but was later found to be ubiquitously expressed in various tissues. The gene encoding miR-22 is found on the short arm of chromosome 17, in a minimal loss of heterozygosity region. It is highly conserved across many vertebrate species, including chimp, mouse, rat, dog and horse. This level of conservation suggests functional importance. MiR-22 was previously identified as having a role in erythrocyte maturation.
Role in cancer
The deregulation of many miRNAs has been shown to have a role in oncogenesis. Mir-22 was found to be over-expressed in prostate cancer but down-regulated in breast cancer, cholangiocarcinoma, multiple myeloma and hepatocellular carcinoma. Mir-22 expression was associated with survival in multiple breast cancer datasets.
Targets
Specifically, miR-22 can function as a tumour suppressor. One known target is histone deacetylase 4, which is known to have a critical role in cancer development. Mir-22 also targets Myc Binding Protein. This prevents transcription of c-Myc target genes by silencing c-MYCBP. However, c-Myc also inhibits expression of miR-22 in a positive feedback loop. When this spirals out of control, it can cause uncontrolled cell proliferation.
Expression of miR-22 can be induced by adding 12-O-Tetradecanoylphorbol-13-acetate to HL-60 cells. The enforced expression causes the growth of cancer cells to slow down. This means that miR-22 could be a potential target for cancer therapies.